23 studies found for:    Pre-exposure prophylaxis AND "PRep" OR "HIV prevention" AND "PRep" | Open Studies | HIV
Show Display Options
Rank Status Study
1 Recruiting A Demonstration Project to Add Pre- or Post-exposure Prophylaxis to Combination HIV Prevention Services
Condition: HIV Prevention
Intervention: Drug: emtricitabine 200mg/tenofovir 300mg
2 Not yet recruiting Comprehensive HIV Prevention Package for MSM in Southern Africa: Pilot Study (Sibanye Health Project)
Condition: HIV
Interventions: Behavioral: Condom choices;   Behavioral: Condom-compatible lubricant choices;   Behavioral: Couples HIV counseling and testing (CVCT);   Drug: Pre-exposure prophylaxis (PrEP) with FTC/TDF;   Other: Staff and provider MSM and LGBT sensitization training;   Behavioral: HIV Testing and Risk-reduction counseling;   Behavioral: Linkage to care
3 Recruiting Evaluating the Safety and Tolerability of Antiretroviral Drug Regimens Used as Pre-Exposure Prophylaxis to Prevent HIV Infection in At-Risk Men Who Have Sex With Men and in At-Risk Women
Condition: HIV Infection
Interventions: Drug: Maraviroc;   Drug: Emtricitabine;   Drug: Tenofovir disoproxil fumarate;   Other: Maraviroc placebo;   Other: Emtricitabine placebo;   Other: Tenofovir disoproxil fumarate placebo
4 Recruiting Exploring HIV Entry Blockade as a Pre-exposure Prophylaxis Strategy in Women
Condition: HIV
Intervention: Drug: maraviroc
5 Recruiting An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis Use Among 15 to 17 Year Old Young Men Who Have Sex With Men (YMSM)
Condition: HIV Infection
Interventions: Behavioral: 3MV;   Behavioral: PCC;   Drug: Emtricitabine/tenofovir (FTC/TDF (Truvada®))
6 Not yet recruiting Sustainable Healthcenter Implementation PrEP Pilot Study
Conditions: HIV Chemoprophylaxis;   HIV Preexposure Prophylaxis
Intervention: Drug: coformulated TDF/FTC
7 Recruiting The ADAPT Study: Use of Emtricitabine and Tenofovir Disoproxil Fumarate for Pre-Exposure Prophylaxis (PrEP)
Condition: HIV Infections
Intervention: Drug: Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF)
8 Recruiting A Prospective, Observational, Drug Utilization Study of Subjects Taking Truvada for Pre-exposure Prophylaxis in the USA
Condition: Pre-exposure Prophylaxis for Prevention of HIV Infection
Intervention:
9 Recruiting HPTN 073 Black Men Who Have Sex With Men (MSM) Pre-Exposure Prophylaxis (PrEP)
Condition: HIV
Intervention: Drug: FTC/TDF
10 Not yet recruiting Implementation of the Pre-Exposure Prophylaxis (PrEP) to HIV: A Demonstrative Project.
Conditions: Prevention and Control;   Preventive Measures;   Preventive Therapy;   Prophylaxis;   HIV Not Infected Subjects
Intervention: Drug: emtricitabine (FTC) / tenofovir (TDF)
11 Recruiting A Prospective, Observational Study of Individuals Who Seroconvert While Taking Truvada® for Pre-Exposure Prophylaxis (PrEP)
Condition: HIV
Intervention:
12 Recruiting Clinician Attitudes and Behaviors Regarding Use of Pre-Exposure Prophylaxis (PrEP) for Primary HIV Prevention
Condition: Clinician Attitudes About PrEP.
Intervention:
13 Recruiting A Prospective, Observational Study of Pregnancy Outcomes Among Women Exposed to Truvada for PrEP Indication
Condition: HIV Infection
Intervention:
14 Recruiting Intervention to Enhance PrEP Uptake and Adherence in a Community-Based Setting
Condition: Human Immunodeficiency Virus (HIV)
Interventions: Behavioral: Sexual Health Counseling;   Behavioral: Enhanced Adherence Intervention;   Behavioral: PrEP Information (Active Control);   Behavioral: Standard of Care Adherence Support (Active Control)
15 Recruiting Couples in Context: An RCT of a Couples-based HIV Prevention Intervention
Condition: HIV Prevention
Intervention: Behavioral: Couples Counselling Sessions
16 Recruiting CCTG 593: Testing and Linkage to Care
Conditions: HIV Positive;   HIV Seronegative
Intervention: Behavioral: Linkage to PrEP or Care
17 Recruiting First Study to Evaluate the Capacity of Maraviroc Drug to Protect Against HIV Infection in Samples of Rectal Mucosa From Healthy Volunteers
Condition: HIV
Interventions: Drug: Maraviroc;   Drug: TVD 300/200 QD
18 Recruiting Seroconversions, Resistance, Adverse Events and Drug Adherence Among Subjects Taking Truvada® for PrEP: A Case Control Study
Condition: HIV
Intervention:
19 Recruiting CCTG 595: Text Messaging Intervention to Improve Adherence to PrEP in High-risk MSM
Conditions: Patient Adherence;   HIV Seronegativity
Intervention: Device: SoC + iTab
20 Unknown  EMBRACE (Evaluation of Maternal and Baby Outcome Registry After Chemoprophylactic Exposure)
Condition: Pregnancy Outcome
Intervention:

Previous Page Studies Shown (1-20) Next Page (21-23) Show next page of results
Indicates status has not been verified in more than two years